Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Traws Pharma, Inc. (TRAW) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Traws Pharma, Inc. (TRAW), most recent 12 months reported: revenue $2.79M, net loss $21.57M, free cash flow -$20.77M. From SEC filings. Others in Pharmaceutical Preparations: Polomar Health Services, Inc. · UPSTREAM BIO, INC. · Connect Biopharma Holdings Limited · BIO ESSENCE CORP. · PMGC HOLDINGS INC. · VISTAGEN THERAPEUTICS, INC. · Korro Bio, Inc. · NORTHWEST BIOTHERAPEUTICS INC

Stock screener

Watchlist